Kestra Medical Technologies, Ltd. (KMTS) has a MoatMap StockRank of 21/100 based on Quality (31/100), Value (36/100), and Momentum (40/100) factor scores. The current signal is SELL. A medical technology firm lacking the scale, regulatory moat, or distribution network of a true compounder, with no connection to our core macro themes.
Kestra Medical Technologies specializes in the development and commercialization of wearable medical devices, primarily focusing on cardiac care and remote patient monitoring. The company aims to improve patient outcomes and comfort through its innovative, discreet, and easy-to-use technology. Kestra targets a niche in personalized, preventative, and responsive cardiac management solutions.
| Price | $19.92 |
| Market Cap | $1.2B |
| P/E (Forward) | -9.56 |
| Price/Book | 4.14 |
| Return on Equity | -92.7% |
| Return on Invested Capital | -41.1% |
| Debt/Equity | 16.16 |
| Gross Margin | 48.8% |
| Operating Margin | -141.6% |
| Revenue Growth | 62.7% |
| Free Cash Flow | $-75M |
Kestra Medical Technologies, Ltd. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).